5/17/24 21:58 | 5/16/24 | GRTS | Health | BioPrd | Biological Products, (No Diag | Allen Andrew R | CA | DO | P,CEO | S.d | -18 | 0.7483 | 0 | -24 | -1 | 2,435 | D | | | | | | | | | | | | | | |
5/17/24 21:57 | 5/16/24 | GRTS | Health | BioPrd | Biological Products, (No Diag | Jones Erin | CA | O | EVP,COO | S.d | -10 | 0.7483 | 0 | -14 | -4 | 359 | D | | | | | | | | | | | | | | |
5/17/24 21:57 | 5/16/24 | GRTS | Health | BioPrd | Biological Products, (No Diag | Jooss Karin | CA | O | See Rema | S.d | -10 | 0.7483 | 0 | -14 | -2 | 684 | D | | | | | | | | | | | | | | |
5/17/24 21:56 | 5/16/24 | GRTS | Health | BioPrd | Biological Products, (No Diag | Hawryluk Matthew | CA | O | EVP,CHIE | S.d | -7 | 0.7483 | 0 | -9 | -3 | 314 | D | | | | | | | | | | | | | | |
5/17/24 21:55 | 5/16/24 | GRTS | Health | BioPrd | Biological Products, (No Diag | Economides Vassiliki | CA | O | EVP,CFO | S.d | -10 | 0.7483 | 0 | -14 | -5 | 262 | D | | | | | | | | | | | | | | |
5/24/23 17:24 | 5/23/23 | GRTS | Health | BioPrd | Biological Products, (No Diag | Economides Vassiliki | CA | O | See Rema | P | 23 | 1.90 | 0 | 12 | 6 | 214 | D | | | | | | | | | | | | | | |
12/3/21 16:47 | 12/1/21 | GRTS | Health | BioPrd | Biological Products, (No Diag | Jones Erin | CA | O | COO | M.d | 0 | 0.3450 | 0 | 1 | 2 | 46 | D | | | | | | | | | | | | | | |
12/3/21 16:47 | 12/1/21 | GRTS | Health | BioPrd | Biological Products, (No Diag | Jones Erin | CA | O | COO | S.d | -13 | 13.01 | 0 | -1 | -2 | 46 | D | | | | | | | | | | | | | | |
12/3/21 16:45 | 11/1/21 | GRTS | Health | BioPrd | Biological Products, (No Diag | Jones Erin | CA | O | COO | M.ad | 0 | 0.3450 | 0 | 1 | 2 | 46 | D | | | | | | | | | | | | | | |
12/3/21 16:45 | 11/1/21 | GRTS | Health | BioPrd | Biological Products, (No Diag | Jones Erin | CA | O | COO | S.ad | -11 | 11.14 | 0 | -1 | -2 | 46 | D | | | | | | | | | | | | | | |
12/3/21 16:43 | 10/1/21 | GRTS | Health | BioPrd | Biological Products, (No Diag | Jones Erin | CA | O | See Rema | M.adm | 1 | 0.3450 | 0 | 2 | 5 | 46 | D | | | | | | | | | | | | | | |
12/3/21 16:43 | 10/1/21 | GRTS | Health | BioPrd | Biological Products, (No Diag | Jones Erin | CA | O | See Rema | S.adm | -21 | 10.70 | 0 | -2 | -4 | 46 | D | | | | | | | | | | | | | | |
11/19/21 18:20 | 3/8/21 | GRTS | Health | BioPrd | Biological Products, (No Diag | Yelensky Roman | CA | O | See Rema | M.ad | 39 | 0.7590 | 0 | 51 | 28 | 235 | D | | | | | | | | | | | | | | |
11/19/21 18:06 | 1/19/21 | GRTS | Health | BioPrd | Biological Products, (No Diag | Yelensky Roman | CA | O | See Rema | S.a | -221 | 22.10 | 0 | -10 | -6 | 161 | D | | | | | | | | | | | | | | |
11/19/21 18:01 | 9/8/21 | GRTS | Health | BioPrd | Biological Products, (No Diag | Jones Erin | CA | O | See Rema | M.ad | 1 | 0.3450 | 0 | 2 | 5 | 46 | D | | | | | | | | | | | | | | |
11/19/21 18:01 | 9/8/21 | GRTS | Health | BioPrd | Biological Products, (No Diag | Jones Erin | CA | O | See Rema | S.ad | -23 | 11.37 | 0 | -2 | -4 | 46 | D | | | | | | | | | | | | | | |
11/3/21 16:42 | 11/1/21 | GRTS | Health | BioPrd | Biological Products, (No Diag | Jones Erin | CA | O | See Rema | M.d | 0 | 0.3450 | 0 | 1 | 5 | 20 | D | | | | | | | | | | | | | | |
11/3/21 16:42 | 11/1/21 | GRTS | Health | BioPrd | Biological Products, (No Diag | Jones Erin | CA | O | See Rema | S.d | -11 | 11.14 | 0 | -1 | -5 | 20 | D | | | | | | | | | | | | | | |
10/5/21 16:30 | 10/1/21 | GRTS | Health | BioPrd | Biological Products, (No Diag | Jones Erin | CA | O | See Rema | M.dm | 1 | 0.3450 | 0 | 2 | 11 | 20 | D | | | | | | | | | | | | | | |
10/5/21 16:30 | 10/1/21 | GRTS | Health | BioPrd | Biological Products, (No Diag | Jones Erin | CA | O | See Rema | S.dm | -21 | 10.70 | 0 | -2 | -9 | 20 | D | | | | | | | | | | | | | | |
9/10/21 16:19 | 9/8/21 | GRTS | Health | BioPrd | Biological Products, (No Diag | Jones Erin | CA | O | See Rema | M.d | 1 | 0.3450 | 0 | 2 | 11 | 20 | D | | | | | | | | | | | | | | |
9/10/21 16:19 | 9/8/21 | GRTS | Health | BioPrd | Biological Products, (No Diag | Jones Erin | CA | O | See Rema | S.d | -23 | 11.37 | 0 | -2 | -9 | 20 | D | | | | | | | | | | | | | | |